The Kintor Pharmaceutical Limited (the 'Company') is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and potential first-in-class KX-826 tincture 1.

All wind signals have been lifted as cyclone Emong continued to weaken into a tropical depression while on its way out of the ...

Grupo Bafar, S.A.B. de C.V. (BIVA: BAFARB), a leading and benchmark company in the national food sector, announced its results for the second quarter of 2025, highlighting sustained growth driven by ...

Purpose Investments Inc. ('Purpose Investments”) announced today its decision to terminate StoneCastle Equity Growth Fund and ...

With America’s aging power grid teetering on the brink of collapse, CrowdPoint Technologies President Nadab U. Akhtar has issued a powerful call to arms: it’s time to stop maintaining the grid-and ...

BlackRock Asset Management Canada Limited ('BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE ...

Interview Kickstart, a leading platform for technical training and interview preparation, offers a Front-End Engineering ...

Rooted in a lifelong commitment to patient-centered care and medical innovation, Dr. Michael Lebow MD created the grant to ...

(All dollar amounts are expressed in Canadian dollars, unless otherwise noted.) ...

Fence and Deck Depot has emphasized the importance of backyard safety, pointing out some less obvious risks that homeowners ...

PharmAla Biotech Holdings Inc. ('PharmAla” or the 'Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the ...